Chinese medical sciences journal = Chung-kuo i hsüeh k'o hsüeh tsa chih / Chinese Academy of Medical Sciences
-
To investigate proliferation and differentiation of neural stem cells in adult rats after cerebral infarction. ⋯ Cerebral infarction stimulate proliferation of inherent neural stem cells and most proliferated neural stem cells differentiate into neurons.
-
Randomized Controlled Trial Clinical Trial
The analysis of changes and influencing factors of early postthoracotomy pulmonary function.
To investigate the changes and influencing factors of early postoperative pulmonary function of thoracotomy. ⋯ Early postoperative pulmonary function is severely impaired by thoracotomy. It rehabilitate gradually with time. Improvement of preoperative pulmonary function, reducing surgical procedure injuries, especially injury to respiratory muscle system, and enough postoperative pain relief are the most important means that would reduce pulmonary function impairment and consequently reduce postoperative pulmonary complications.
-
Randomized Controlled Trial Comparative Study Clinical Trial
Clinical study of patient-controlled epidural analgesia with tetracaine hydrochloride after pulmonary lobectomy.
To investigate the efficacy and safety of tetracaine hydrochloride in patient-controlled epidural analgesia (PCEA) after pulmonary lobectomy. ⋯ The analgesic effect of 0.15% tetracaine is similar to that of 0.3% ropivacaine used in patient-controlled epidural analgesia after thoracotomy. No serious side effects were observed.
-
To investigate the high risk factors, clinical features, diagnosis and treatment of pulmonary embolism (PE) during pregnancy and the postpartum period. ⋯ The maternal mortality of PE during pregnancy and postpartum period is quite high. Whenever there is any doubt, objective examinations for PE should be started early in order to strive for the chances of the anticoagulant therapy.
-
Randomized Controlled Trial Comparative Study Clinical Trial
Clinical comparison of the selective serotonin3 antagonists ramosetron and granisetron in treating acute chemotherapy-induced emesis, nausea and anorexia.
The efficacies of the selective 5-hydroxytryptamine3 (5-HT3) antagonists--ramosetron (0.3 mg) and granisetron (3 mg) in treating acute chemotherapy-induced digestive system dysunction were compared. ⋯ Ramosetron is more potent and longer-lasting than granisetron in preventing chemotherapy-induced digestive disturbances.